Flagship Pioneering Special Opportunities Fund Ii, L.p. - Net Worth and Insider Trading
Flagship Pioneering Special Opportunities Fund Ii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Flagship Pioneering Special Opportunities Fund Ii, L.p. owns 3 companies in total, including Foghorn Therapeutics Inc (FHTX) , Sigilon Therapeutics Inc (SGTX) , and Omega Therapeutics Inc (OMGA) .
Insider Ownership Summary of Flagship Pioneering Special Opportunities Fund Ii, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FHTX | Foghorn Therapeutics Inc | 2020-10-22 | 10 percent owner |
SGTX | Sigilon Therapeutics Inc | 2020-12-03 | 10 percent owner |
OMGA | Omega Therapeutics Inc | 2021-07-29 | 10 percent owner |
Flagship Pioneering Special Opportunities Fund Ii, L.p. Trading Performance
Flagship Pioneering Special Opportunities Fund Ii, L.p. Ownership Network
Flagship Pioneering Special Opportunities Fund Ii, L.p. Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Flagship Pioneering Special Opportunities Fund Ii, L.p. is the 10 percent owner of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief People Officer Carlos Costa , See Remarks Steven F. Bellon , and Chief Strategy/Bus Ops Officer Fanny Cavalie .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Flagship Pioneering Special Opportunities Fund Ii, L.p. made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 311,297 shares made by Samuel Agresta , a net sale of 20,000 shares made by Steven F. Bellon , and a net sale of 11,000 shares made by Fanny Cavalie .
In summary, during the past 3 months, insiders sold 30,672 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 30,672 shares. During the past 18 months, 352,969 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 352,969 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Flagship Pioneering Special Opportunities Fund Ii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Flagship Pioneering Special Opportunities Fund Ii, L.p.. You might contact Flagship Pioneering Special Opportunities Fund Ii, L.p. via mailing address: 55 Cambridge Parkway, Cambridge Ma 02142.